Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990‐2019
Despite the tremendous burden of liver cancer and its underlying causes on humankind, there appear to be heterogeneities in coping approaches. The objective of this study was to compare the burden and the quality‐of‐care of liver cancer by causes among different countries and regions in both sexes a...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2022-07-01
|
| Series: | Hepatology Communications |
| Online Access: | https://doi.org/10.1002/hep4.1910 |
| _version_ | 1811174099789021184 |
|---|---|
| author | Seyyed‐Hadi Ghamari Moein Yoosefi Mohsen Abbasi‐Kangevari Mohammad‐Reza Malekpour Sahar Saeedi Moghaddam Sarvenaz Shahin Zahra Esfahani Sogol Koolaji Parnian Shobeiri Aydin Ghaffari Hanye Sohrabi Ameneh Kazemi Negar Rezaei Bagher Larijani Farshad Farzadfar |
| author_facet | Seyyed‐Hadi Ghamari Moein Yoosefi Mohsen Abbasi‐Kangevari Mohammad‐Reza Malekpour Sahar Saeedi Moghaddam Sarvenaz Shahin Zahra Esfahani Sogol Koolaji Parnian Shobeiri Aydin Ghaffari Hanye Sohrabi Ameneh Kazemi Negar Rezaei Bagher Larijani Farshad Farzadfar |
| author_sort | Seyyed‐Hadi Ghamari |
| collection | DOAJ |
| description | Despite the tremendous burden of liver cancer and its underlying causes on humankind, there appear to be heterogeneities in coping approaches. The objective of this study was to compare the burden and the quality‐of‐care of liver cancer by causes among different countries and regions in both sexes and various age groups 1990‐2019. Data of liver cancer and underlying causes, including hepatitis B virus (HBV), hepatitis C virus (HCV), alcohol use, nonalcoholic steatohepatitis (NASH), and other causes were obtained from the Global Burden of Diseases 2019. Incidence, prevalence, death, and disability‐adjusted life‐years (DALYs) were assessed. Principal component analysis was used to combine age‐standardized mortality‐to‐incidence ratio, DALY‐to‐prevalence ratio, prevalence‐to‐incidence ratio, and years of life lost–to–years lived with disability into a single proxy named Quality of Care Index (QCI). Globally, the age‐standardized incidence, DALYs, and death rates decreased from 1990 to 2019, while the QCI scores increased by 68.5%. The QCI score of liver cancer was from as high as 83.3 in high Sociodemographic Index (SDI) countries to values as low as 26.4 in low SDI countries in 2019. Japan had the highest QCI score (QCI = 100). The age‐standardized death rates of liver cancer due to all underlying causes were decreasing during the past 30 years, with the most decrease for HBV. Consistently, the global QCI scores of liver cancer due to HBV, HCV, alcohol use, NASH, and other causes reached 53.5, 61.8, 54.3, 52.9, and 63.7, respectively, in 2019. Conclusion: Although the trends in burden are decreasing and the QCI improved from 1990 to 2019 globally, there is a wide gap between countries. Given the inequities in health care quality, there is an urgent need to address discrimination and bridge the gap. |
| first_indexed | 2024-04-10T17:57:41Z |
| format | Article |
| id | doaj.art-c6d599a67e764d4c8deeadee920e8ca9 |
| institution | Directory Open Access Journal |
| issn | 2471-254X |
| language | English |
| last_indexed | 2024-04-10T17:57:41Z |
| publishDate | 2022-07-01 |
| publisher | Wolters Kluwer Health/LWW |
| record_format | Article |
| series | Hepatology Communications |
| spelling | doaj.art-c6d599a67e764d4c8deeadee920e8ca92023-02-02T17:27:39ZengWolters Kluwer Health/LWWHepatology Communications2471-254X2022-07-01671764177510.1002/hep4.1910Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990‐2019Seyyed‐Hadi Ghamari0Moein Yoosefi1Mohsen Abbasi‐Kangevari2Mohammad‐Reza Malekpour3Sahar Saeedi Moghaddam4Sarvenaz Shahin5Zahra Esfahani6Sogol Koolaji7Parnian Shobeiri8Aydin Ghaffari9Hanye Sohrabi10Ameneh Kazemi11Negar Rezaei12Bagher Larijani13Farshad Farzadfar14Non‐communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran IranNon‐communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran IranNon‐communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran IranNon‐communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran IranNon‐communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran IranNon‐communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran IranNon‐communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran IranNon‐communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran IranNon‐communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran IranNon‐communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran IranNon‐communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran IranNon‐communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran IranNon‐communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran IranEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute Tehran University of Medical Sciences Tehran IranNon‐communicable Diseases Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran IranDespite the tremendous burden of liver cancer and its underlying causes on humankind, there appear to be heterogeneities in coping approaches. The objective of this study was to compare the burden and the quality‐of‐care of liver cancer by causes among different countries and regions in both sexes and various age groups 1990‐2019. Data of liver cancer and underlying causes, including hepatitis B virus (HBV), hepatitis C virus (HCV), alcohol use, nonalcoholic steatohepatitis (NASH), and other causes were obtained from the Global Burden of Diseases 2019. Incidence, prevalence, death, and disability‐adjusted life‐years (DALYs) were assessed. Principal component analysis was used to combine age‐standardized mortality‐to‐incidence ratio, DALY‐to‐prevalence ratio, prevalence‐to‐incidence ratio, and years of life lost–to–years lived with disability into a single proxy named Quality of Care Index (QCI). Globally, the age‐standardized incidence, DALYs, and death rates decreased from 1990 to 2019, while the QCI scores increased by 68.5%. The QCI score of liver cancer was from as high as 83.3 in high Sociodemographic Index (SDI) countries to values as low as 26.4 in low SDI countries in 2019. Japan had the highest QCI score (QCI = 100). The age‐standardized death rates of liver cancer due to all underlying causes were decreasing during the past 30 years, with the most decrease for HBV. Consistently, the global QCI scores of liver cancer due to HBV, HCV, alcohol use, NASH, and other causes reached 53.5, 61.8, 54.3, 52.9, and 63.7, respectively, in 2019. Conclusion: Although the trends in burden are decreasing and the QCI improved from 1990 to 2019 globally, there is a wide gap between countries. Given the inequities in health care quality, there is an urgent need to address discrimination and bridge the gap.https://doi.org/10.1002/hep4.1910 |
| spellingShingle | Seyyed‐Hadi Ghamari Moein Yoosefi Mohsen Abbasi‐Kangevari Mohammad‐Reza Malekpour Sahar Saeedi Moghaddam Sarvenaz Shahin Zahra Esfahani Sogol Koolaji Parnian Shobeiri Aydin Ghaffari Hanye Sohrabi Ameneh Kazemi Negar Rezaei Bagher Larijani Farshad Farzadfar Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990‐2019 Hepatology Communications |
| title | Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990‐2019 |
| title_full | Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990‐2019 |
| title_fullStr | Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990‐2019 |
| title_full_unstemmed | Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990‐2019 |
| title_short | Trends in Global, Regional, and National Burden and Quality of Care Index for Liver Cancer by Cause from Global Burden of Disease 1990‐2019 |
| title_sort | trends in global regional and national burden and quality of care index for liver cancer by cause from global burden of disease 1990 2019 |
| url | https://doi.org/10.1002/hep4.1910 |
| work_keys_str_mv | AT seyyedhadighamari trendsinglobalregionalandnationalburdenandqualityofcareindexforlivercancerbycausefromglobalburdenofdisease19902019 AT moeinyoosefi trendsinglobalregionalandnationalburdenandqualityofcareindexforlivercancerbycausefromglobalburdenofdisease19902019 AT mohsenabbasikangevari trendsinglobalregionalandnationalburdenandqualityofcareindexforlivercancerbycausefromglobalburdenofdisease19902019 AT mohammadrezamalekpour trendsinglobalregionalandnationalburdenandqualityofcareindexforlivercancerbycausefromglobalburdenofdisease19902019 AT saharsaeedimoghaddam trendsinglobalregionalandnationalburdenandqualityofcareindexforlivercancerbycausefromglobalburdenofdisease19902019 AT sarvenazshahin trendsinglobalregionalandnationalburdenandqualityofcareindexforlivercancerbycausefromglobalburdenofdisease19902019 AT zahraesfahani trendsinglobalregionalandnationalburdenandqualityofcareindexforlivercancerbycausefromglobalburdenofdisease19902019 AT sogolkoolaji trendsinglobalregionalandnationalburdenandqualityofcareindexforlivercancerbycausefromglobalburdenofdisease19902019 AT parnianshobeiri trendsinglobalregionalandnationalburdenandqualityofcareindexforlivercancerbycausefromglobalburdenofdisease19902019 AT aydinghaffari trendsinglobalregionalandnationalburdenandqualityofcareindexforlivercancerbycausefromglobalburdenofdisease19902019 AT hanyesohrabi trendsinglobalregionalandnationalburdenandqualityofcareindexforlivercancerbycausefromglobalburdenofdisease19902019 AT amenehkazemi trendsinglobalregionalandnationalburdenandqualityofcareindexforlivercancerbycausefromglobalburdenofdisease19902019 AT negarrezaei trendsinglobalregionalandnationalburdenandqualityofcareindexforlivercancerbycausefromglobalburdenofdisease19902019 AT bagherlarijani trendsinglobalregionalandnationalburdenandqualityofcareindexforlivercancerbycausefromglobalburdenofdisease19902019 AT farshadfarzadfar trendsinglobalregionalandnationalburdenandqualityofcareindexforlivercancerbycausefromglobalburdenofdisease19902019 |